# Extra Space Storage Inc.: financial statements, quarterly

EXR · NYSE · CIK 1289490 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/exr.md) · [Financials](/companies/exr/financials.md) · [Filings](/companies/exr/filings.md) · [Insiders](/companies/exr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/exr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [28.0](/filings/0001628280-24-045038.md) | [30.4 d](/filings/0001289490-26-000011.md) | [30.1](/filings/0001628280-25-021878.md) | [29.9](/filings/0001289490-25-000011.md) | [29.9](/filings/0001289490-25-000024.md) | [31.0 d](/filings/0001289490-26-000011.md) | [30.9](/filings/0001289490-26-000037.md) | [32.0](/filings/0001289490-26-000053.md) | [32.5](/filings/0001289490-25-000024.md) | [34.0 d](/filings/0001289490-26-000011.md) | [33.7](/filings/0001289490-26-000037.md) | [34.9](/filings/0001289490-26-000053.md) |
| Cost of revenue | $m | [185](/filings/0001628280-24-045038.md) | [195 d](/filings/0001289490-26-000011.md) | [205](/filings/0001628280-25-021878.md) | [197](/filings/0001289490-25-000011.md) | [209](/filings/0001289490-25-000024.md) | [221 d](/filings/0001289490-26-000011.md) | [224](/filings/0001289490-26-000037.md) | [228](/filings/0001289490-26-000053.md) | [235](/filings/0001289490-25-000024.md) | [231 d](/filings/0001289490-26-000011.md) | [238](/filings/0001289490-26-000037.md) | [232](/filings/0001289490-26-000053.md) |
| Operating income | $m | [300](/filings/0001628280-24-045038.md) | [333 d](/filings/0001289490-26-000011.md) | [336](/filings/0001628280-25-021878.md) | [305](/filings/0001289490-25-000011.md) | [303](/filings/0001289490-25-000024.md) | [380 d](/filings/0001289490-26-000011.md) | [389](/filings/0001289490-26-000037.md) | [374](/filings/0001289490-26-000053.md) | [279](/filings/0001289490-25-000024.md) | [371 d](/filings/0001289490-26-000011.md) | [368](/filings/0001289490-26-000037.md) | [392](/filings/0001289490-26-000053.md) |
| Interest expense | $m | [123](/filings/0001628280-23-038325.md) | [130 d](/filings/0001628280-24-008044.md) | [133](/filings/0001628280-24-020317.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.9](/filings/0001628280-24-045038.md) | [4.3 d](/filings/0001289490-26-000011.md) | [6.7](/filings/0001628280-25-021878.md) | [9.8](/filings/0001289490-25-000011.md) | [10.9](/filings/0001289490-25-000024.md) | [6.0 d](/filings/0001289490-26-000011.md) | [9.0](/filings/0001289490-26-000037.md) | [11.6](/filings/0001289490-26-000053.md) | [12.0](/filings/0001289490-25-000024.md) | [9.0 d](/filings/0001289490-26-000011.md) | [10.8](/filings/0001289490-26-000037.md) | [12.1](/filings/0001289490-26-000053.md) |
| Net income | $m | [188](/filings/0001628280-24-045038.md) | [216 d](/filings/0001289490-26-000011.md) | [213](/filings/0001628280-25-021878.md) | [186](/filings/0001289490-25-000011.md) | [193](/filings/0001289490-25-000024.md) | [262 d](/filings/0001289490-26-000011.md) | [271](/filings/0001289490-26-000037.md) | [250](/filings/0001289490-26-000053.md) | [166](/filings/0001289490-25-000024.md) | [287 d](/filings/0001289490-26-000011.md) | [241](/filings/0001289490-26-000037.md) | [263](/filings/0001289490-26-000053.md) |
| Diluted EPS | $ per share | [0.96](/filings/0001628280-24-045038.md) | not reported | [1.01](/filings/0001628280-25-021878.md) | [0.88](/filings/0001289490-25-000011.md) | [0.91](/filings/0001289490-25-000024.md) | not reported | [1.28](/filings/0001289490-26-000037.md) | [1.18](/filings/0001289490-26-000053.md) | [0.78](/filings/0001289490-25-000024.md) | not reported | [1.14](/filings/0001289490-26-000037.md) | [1.25](/filings/0001289490-26-000053.md) |
| Basic EPS | $ per share | [0.96](/filings/0001628280-24-045038.md) | not reported | [1.01](/filings/0001628280-25-021878.md) | [0.88](/filings/0001289490-25-000011.md) | [0.91](/filings/0001289490-25-000024.md) | not reported | [1.28](/filings/0001289490-26-000037.md) | [1.18](/filings/0001289490-26-000053.md) | [0.78](/filings/0001289490-25-000024.md) | not reported | [1.14](/filings/0001289490-26-000037.md) | [1.25](/filings/0001289490-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001628280-24-045038.md) | [0.1](/filings/0001289490-26-000011.md) | [0.1](/filings/0001628280-25-021878.md) | [0.1](/filings/0001289490-25-000011.md) | [0.1](/filings/0001289490-25-000024.md) | [0.1](/filings/0001289490-26-000053.md) | [0.1](/filings/0001289490-26-000037.md) | [0.1](/filings/0001289490-26-000053.md) | [0.1](/filings/0001289490-25-000024.md) | [0.1](/filings/0001289490-26-000053.md) | [0.1](/filings/0001289490-26-000037.md) | [0.7](/filings/0001289490-26-000053.md) |
| Total assets | $bn | [27.6](/filings/0001628280-23-038325.md) | [27.5](/filings/0001628280-25-009060.md) | [27.5](/filings/0001628280-24-020317.md) | [27.8](/filings/0001628280-24-034445.md) | [28.1](/filings/0001628280-24-045038.md) | [28.8](/filings/0001289490-26-000011.md) | [29.0](/filings/0001628280-25-021878.md) | [29.4](/filings/0001289490-25-000011.md) | [29.2](/filings/0001289490-25-000024.md) | [29.3](/filings/0001289490-26-000053.md) | [29.1](/filings/0001289490-26-000037.md) | [29.7](/filings/0001289490-26-000053.md) |
| Total liabilities | $bn | [12.1](/filings/0001628280-23-038325.md) | [12.0](/filings/0001628280-25-009060.md) | [12.2](/filings/0001628280-24-020317.md) | [12.6](/filings/0001628280-24-034445.md) | [13.1](/filings/0001628280-24-045038.md) | [14.0](/filings/0001289490-26-000011.md) | [14.2](/filings/0001628280-25-021878.md) | [14.7](/filings/0001289490-25-000011.md) | [14.7](/filings/0001289490-25-000024.md) | [14.9](/filings/0001289490-26-000053.md) | [14.9](/filings/0001289490-26-000037.md) | [15.5](/filings/0001289490-26-000053.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | [0.5](/filings/0001628280-25-009060.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [14.5](/filings/0001628280-23-038325.md) | [14.4](/filings/0001628280-25-009060.md) | [14.3](/filings/0001628280-24-020317.md) | [14.2](/filings/0001628280-24-034445.md) | [14.0](/filings/0001628280-24-045038.md) | [13.9](/filings/0001289490-26-000011.md) | [13.9](/filings/0001628280-25-021878.md) | [13.8](/filings/0001289490-25-000011.md) | [13.6](/filings/0001289490-25-000024.md) | [13.4](/filings/0001289490-26-000053.md) | [13.3](/filings/0001289490-26-000037.md) | [13.3](/filings/0001289490-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [408 d](/filings/0001628280-24-045038.md) | [365 d](/filings/0001289490-26-000011.md) | [466](/filings/0001628280-25-021878.md) | [545 d](/filings/0001289490-25-000011.md) | [468 d](/filings/0001289490-25-000024.md) | [408 d](/filings/0001289490-26-000011.md) | [481](/filings/0001289490-26-000037.md) | [544 d](/filings/0001289490-26-000053.md) | [457 d](/filings/0001289490-25-000024.md) | [368 d](/filings/0001289490-26-000011.md) | [490](/filings/0001289490-26-000037.md) | [586 d](/filings/0001289490-26-000053.md) |
| Capital expenditure | $m | [18.6](/filings/0001628280-24-045038.md) | [71.0 d](/filings/0001628280-25-009060.md) | [35.1](/filings/0001289490-25-000024.md) | [27.6](/filings/0001289490-25-000024.md) | [158](/filings/0001289490-25-000024.md) | [258 d](/filings/0001289490-26-000011.md) | [117](/filings/0001289490-26-000053.md) | [162](/filings/0001289490-26-000053.md) | [12.9](/filings/0001289490-25-000024.md) | [251 d](/filings/0001289490-26-000011.md) | [12.4](/filings/0001289490-26-000053.md) | [86.8](/filings/0001289490-26-000053.md) |
| Dividends paid | $m | [265 d](/filings/0001628280-24-045038.md) | [342 d](/filings/0001289490-26-000011.md) | [344](/filings/0001628280-25-021878.md) | [343 d](/filings/0001289490-25-000011.md) | [343 d](/filings/0001289490-25-000024.md) | [344 d](/filings/0001289490-26-000011.md) | [344](/filings/0001289490-26-000037.md) | [344 d](/filings/0001289490-26-000053.md) | [344 d](/filings/0001289490-25-000024.md) | [342 d](/filings/0001289490-26-000011.md) | [343](/filings/0001289490-26-000037.md) | [342 d](/filings/0001289490-26-000053.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-23-038325.md) | [0.0 d](/filings/0001289490-26-000011.md) | not reported | not reported | [0.0 d](/filings/0001289490-25-000024.md) | [0.0 d](/filings/0001289490-26-000011.md) | [0.0](/filings/0001289490-26-000037.md) | [8.6 d](/filings/0001289490-26-000053.md) | [0.0 d](/filings/0001289490-25-000024.md) | [141 d](/filings/0001289490-26-000011.md) | [1.4](/filings/0001289490-26-000037.md) | [0.0 d](/filings/0001289490-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [142](/filings/0001628280-23-038325.md) | [143](/filings/0001628280-24-020317.md) | [144](/filings/0001628280-24-034445.md) | [195](/filings/0001628280-24-045038.md) | [220](/filings/0001628280-25-021878.md) | [212](/filings/0001289490-25-000011.md) | [220](/filings/0001289490-25-000024.md) | [212](/filings/0001289490-26-000037.md) | [212](/filings/0001289490-26-000053.md) | [221](/filings/0001289490-25-000024.md) | [220](/filings/0001289490-26-000037.md) | [220](/filings/0001289490-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 211,269,558 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001289490-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.